CORCEPT THERAPEUTICS INC Increase (Decrease) in Deferred Income Taxes
CORCEPT THERAPEUTICS INC (CORT) reported Increase (Decrease) in Deferred Income Taxes of -$1.80 million for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2020-11-03
- CORCEPT THERAPEUTICS INC increase (decrease) in deferred income taxes for the quarter ending 2020-09-30 was -$1.80M.
- CORCEPT THERAPEUTICS INC increase (decrease) in deferred income taxes for the quarter ending 2020-06-30 was -$4.90M.
- CORCEPT THERAPEUTICS INC increase (decrease) in deferred income taxes for the quarter ending 2020-03-31 was -$5.10M.
- CORCEPT THERAPEUTICS INC increase (decrease) in deferred income taxes for the quarter ending 2019-09-30 was -$5.90M.
| Period end | Increase (Decrease) in Deferred Income Taxes 3 month | Increase (Decrease) in Deferred Income Taxes 3 month as first filed | Increase (Decrease) in Deferred Income Taxes 6 month | Increase (Decrease) in Deferred Income Taxes 6 month as first filed | Increase (Decrease) in Deferred Income Taxes 9 month |
|---|---|---|---|---|---|
| 2020-09-30 | -$1.80M 10-Q · filed 2020-11-03 | -$6.70M derived: sum of 2 quarters · filed 2020-11-03 | -$11.80M 10-Q · filed 2020-11-03 | ||
| 2020-06-30 | -$4.90M 10-Q · filed 2020-08-04 | -$10.00M 10-Q · filed 2020-08-04 | |||
| 2020-03-31 | -$5.10M 10-Q · filed 2020-05-04 | ||||
| 2019-09-30 | -$5.90M 10-Q · filed 2020-11-03 | -$10.80M derived: sum of 2 quarters · filed 2020-11-03 | -$11.70M 10-Q · filed 2020-11-03 | ||
| 2019-06-30 | -$4.90M 10-Q · filed 2020-08-04 | -$5.80M 10-Q · filed 2020-08-04 | |||
| 2019-03-31 | -$900.00K 10-Q · filed 2020-05-04 | ||||
| 2018-09-30 | -$5.00M 10-Q · filed 2019-11-07 | -$7.50M derived: sum of 2 quarters · filed 2019-11-07 | -$10.60M 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | -$2.50M 10-Q · filed 2019-08-01 | $2.50M 10-Q · filed 2018-08-09 | -$5.60M 10-Q · filed 2019-08-01 | $5.60M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | -$3.20M 10-Q · filed 2019-05-09 | $3.20M 10-Q · filed 2018-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |